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Purpose. To compare the corneal endothelial cell loss after phacoemulsification, alone or combined with microinvasive glaucoma
surgery (MIGS), in nonglaucomatous versus primary open angle glaucoma (POAG) eyes affected by age-related cataract.Methods.
62 eyes of 62 patients were divided into group 1 (𝑛 = 25, affected by age-related cataract) and group 2 (𝑛 = 37, affected by age-related
cataract and POAG). All patients underwent cataract surgery. Group 2 was divided into subgroups A (𝑛 = 19, cataract surgery
alone) and B (𝑛 = 18, cataract surgery andMIGS). Prior to and 6months after surgery the patients’ endothelium was studied. Main
outcomeswereCD (cell density), SD (standard deviation), CV (coefficient of variation), and 6A (hexagonality coefficient) variations
after surgeries. Results. There were no significant differences among the groups concerning preoperative endothelial parameters.
The differences in CD before and after surgery were significant in all groups: 9.1% in group 1, 17.24% in group 2A, and 11.71% in
group 2B. All endothelial parameters did not significantly change after surgery.Conclusions. Phacoemulsification determined a loss
of endothelial cells in all groups. After surgery the change in endothelial parameters after MIGS was comparable to the ones of
patients who underwent cataract surgery alone.
1. Introduction
The high rate of complications of traditional glaucoma
surgery (trabeculectomy) has prompted the glaucoma com-
munity to search for alternative surgeries to treat primary
open angle glaucoma (POAG) [1]. Recently, the interest for
less invasive glaucoma surgeries has significantly increased.
These new techniques have been collectively defined as
microinvasive glaucoma surgery (MIGS).While tube surgery
is generally reserved to cases where trabeculectomy is con-
sidered ineffective or has previously failed [2, 3], MIGS is
recommended for initial to moderate glaucoma.
Most of the MIGS imply the insertion of a draining
stent in the anterior chamber angle. The Hydrus microstent
(Hydrus, Ivantis, Irvine, CA) is inserted into Schlemm’s canal,
bypassing the trabecular meshwork and providing direct
aqueous access to Schlemm’s canal.
It is known that the corneal endothelial cell density
(EDC) progressively decreases over time [4, 5] and that any
implant within the anterior chamber can result in progressive
endothelial cell loss [4, 6–8]. Anterior chamber IOLs [9,
10] and tube surgery can determine endothelial damage:
although the exact mechanism causing the damage after
tube surgery is mostly unknown, the frequency of corneal
complications after Ahmed Glaucoma Valve (AGV) implant
surgery has been reported to be 27% after long-term follow-
up [11].
Due to the often coexisting age-related cataract and to
the easiness of a combined procedure, MIGS are best used in
conjunction with cataract surgery, which can cause by itself
damage to the corneal endothelium [12].
The effect of cataract surgery and MIGS implant on the
corneal endothelium has not been previously investigated.
This prospective study compares the corneal endothelial
cell loss after phacoemulsification in nonglaucomatous eyes
to phacoemulsification in POAG eyes with and without
combined MIGS implant over a six-month period.
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Table 1: Preoperative demographic and operative data of the patients (mean ± standard deviation; LOCS: lens opacity classification system;
CD: cell density; SD: standard deviation; CV: coefficient of variation; 6A: hexagonality coefficient; US: ultrasound; 𝑝: 𝑝 value; N/A: not
applicable).
Group 1 2A 2B 𝑝 1 versus 2A 𝑝 1 versus 2B 𝑝 2A versus 2B
Mean age (yrs) 70.3 ± 2.5 68.8 ± 2.7 69.6 ± 2.2 0.064 0.347 0.332
Gender m/f (%) 17 (68)/8 (32) 9 (47.4)/10 (52.6) 15 (82.4)/4 (17.6) N/A N/A N/A
Cataract grade (LOCS III) 3.71 ± 0.9 3.4 ± 0.8 3.64 ± 1.2 0.242 0.828 0.477
CD (cell/mm2) 2361.7 ± 477.9 2234.5 ± 344.7 2476.2 ± 300.6 0.332 0.376 0.052
SD (𝜇m2) 171.8 ± 84.2 173.8 ± 63.4 155.5 ± 41.9 0.932 0.455 0.31
CV 37.6 ± 9.8 36.9 ± 9.8 37.3 ± 8.2 0.816 0.916 0.894
6A (%) 57.6 ± 10.5 55.5 ± 13.1 56.3 ± 7.5 0.558 0.656 0.822
Total surgical time (mins) 12.3 ± 2.5 12 ± 1.9 18.45 ± 2.9 0.665 <0.001 <0.001
Phacoemulsification time (sec) 37.1 ± 19.7 34 ± 18.4 35.4 ± 17 0.598 0.769 0.812
US power (%) 20.8 ± 12 18.9 ± 6.1 20.5 ± 10.3 0.532 0.932 0.567
2. Materials and Methods
This is a nonrandomised retrospective study on 62 consecu-
tive patients, affected by uncomplicated age-related cataract.
Patients have been divided into two groups: group 1 was
affected by age-related cataract (𝑛 = 25) and group 2
presented age-related cataract and POAG (𝑛 = 37).
Patients were included if they had a diagnosis of age-
related cataract, age between 55 and 84 years, corneal thick-
ness (using ultrasound contact pachymetry) between 480
and 620 microns, absence of corneal dystrophies, central
endothelial cell count of at least 1500 cells/mm2, no history of
previous ocular surgery, no history of previous ocular inflam-
mation/infection, and absence of other major eye diseases
(diabetic retinopathy and age-related macular disease).
After full explanation of study procedures and signature
of an informed consent, consecutive patients fulfilling these
criteria and willing to participate to the study were recruited.
The study protocol was approved by our local ethics commit-
tee.
Patients with a previous diagnosis of POAG confirmed by
optic nerve evaluation, visual field, and a medicated IOP at
the screening visit lower than 24mmHgwere placed in group
2. POAG subjects were excluded if they were usingmore than
four medications or if they were on oral hypotensive drugs.
Patients in group 1 underwent cataract surgery alone,
while patients in group 2 were randomly divided into two
subgroups. Patients in subgroup 2A (𝑛 = 19) underwent
cataract surgery alone, while those in subgroup 2B (𝑛 =
18) underwent a combined procedure (cataract surgery
and Hydrus stent implantation). Patients characteristics are
resumed in Table 1.
2.1. Surgical Procedure. All surgical procedures were per-
formedby a single surgeon (AMF) according to the procedure
described below. Cataract surgical times, total phacoemulsi-
fication times, and the percentage of ultrasound power for
each procedurewere recorded at the endof every intervention
(Table 1).
All patients underwent cataract surgery with phacoemul-
sification through a 2.2mm eleven o’clock clear corneal
incision. After injection of a dispersive viscoelastic device
(OVD) (Viscoat, Alcon laboratories, Fort Worth, TX), a
6mm diameter capsulorhexis was carried out. Phacoemul-
sification and irrigation/aspiration of cortical material were
performed using the same phacoemulsification instrument
(AMO Signature White Star, Abbot, Chicago, IL). Then, a
cohesive OVD (Provisc, Alcon) was injected in the capsular
bag and a foldable single piece monofocal IOL was inserted
in the capsular bag. The same IOL was implanted in all
cases (Tecnis ZCB00, Abbott Laboratories Inc., Abbott Park,
Illinois, USA). The OVD was completely removed from the
anterior chamber (AC) and from the capsular bag using a
monomanual irrigation-aspiration system.
After phacoemulsification, the patients who underwent
combined surgery (group 2B) had the microscope repo-
sitioned and the head tilted to allow a clear view of the
angle structures with a gonioprism. Additional viscoelastic
device (Healon GV, Abbott) was introduced for chamber
maintenance and optimum view. The Hydrus delivery can-
nula was inserted through a 1–1.5mm secondary temporal
incision.The beveled tip of the cannula was used to perforate
the trabecular meshwork and the microstent was implanted
into Schlemm’s canal by advancing the tracking wheel with
the index finger, leaving 1-2mm (the inlet segment) in the
anterior chamber in the nasal quadrant. Upon gonioscopic
confirmation of position in the canal, the delivery system
was withdrawn and viscoelastic device removed; the AC was
inflated with balanced salt solution to achieve normal IOP.
At the end of surgery the eye was inflated through the
accessory wound. No sutures were needed to seal the wound.
Postoperative care included a topical antibiotic for 4–7
days and a tapering dose of a topical corticosteroid for 4weeks
in all groups.
2.2. Endothelium Analysis. The endothelium was studied
using the proprietary software of the Konan Cell Check XL
(Konan Medical, Irvine, CA, USA). CD (cell density), SD
(standard deviation), CV (coefficient of variation), and 6A
(hexagonality coefficient) were evaluated. The endothelium
was examined before intervention and 6months after surgery.
The examinations were performed by an expert operator
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Table 2: Difference and statistical analysis between preoperative and postoperative parameters (mean ± standard deviation; CD: cell density;
SD: standard deviation; CV: coefficient of variation; 6A = hexagonality coefficient).
Group Parameters CD SD CV 6A
1
Preoperative 2361.7 ± 477.9 171.8 ± 84.2 37.6 ± 9.8 57.6 ± 10.5
Postoperative 2147.3 ± 455.7 178.7 ± 63.9 38.1 ± 8.7 51.4 ± 10.1
Difference −214.4 ± 362.6 6.92 ± 77.1 0.52 ± 10.2 −6.24 ± 11.9
𝑡-test 2.956 0.449 0.256 2.607
𝑝 value 0.007 0.658 0.800 0.015
2A
Preoperative 2234.5 ± 344.7 173.8 ± 63.4 36.9 ± 9.8 55.5 ± 13.1
Postoperative 1872.4 ± 393.5 216.7 ± 66.3 37.8 ± 8.1 55.9 ± 8.9
Difference −362.1 ± 316 42.9 ± 71.2 0.95 ± 11.1 0.47 ± 11.9
𝑡-test 4.995 2.63 0.373 0.173
𝑝 value <0.001 0.017 0.713 0.865
2B
Preoperative 2476.2 ± 300.6 155.5 ± 41.9 37.3 ± 8.2 56.3 ± 7.5
Postoperative 2185.8 ± 393.1 170.8 ± 50.1 36.2 ± 7.5 62.5 ± 10
Difference −290.3 ± 322.4 15.3 ± 62.6 −1.1 ± 12 6.2 ± 12.2
𝑡-test 4.592 1.25 0.459 2.573
𝑝 value <0.001 0.224 0.65 0.016
(CAL) and endothelial cell data were based on the average
of the three measurements in the central cornea with the best
clarity at each site. Images of low quality were excluded and
the examination was repeated until they were clear enough.
If it was not possible, the patients were excluded from the
study. Endothelial cells were analyzed using the dot method,
in which the sites of approximately 80–100 contiguous cells
were marked. One glaucoma specialist (AMF) interpreted all
endothelial cell data. Endothelial damage was defined as the
difference between the preoperative and postoperative values.
2.3. Statistical Analysis. One sample 𝑡-test was performed
for data comparison within groups and two-sample 𝑡-test
for data comparison between groups. Statistical analysis was
performed using Analyse-it statistical software for Microsoft
Excel (version 2.26;Analyse-it software, Leeds,UK).The limit
of statistical significance was set at 𝑝 ≤ 0.05.
3. Results
Preoperative data regarding the patients are reported in
Table 1. There were no significant differences between the
groups for age and cataract grade (LOCS III) [13].
Preoperatively, the mean CD was 2361.7 ±
477.9 cells/mm2 in group 1, 2234.5± 344.7 cells/mm2 in group
2A, and 2476.2 ± 300.6 cells/mm2 in group 2B (Table 1).
There were no statistically significant differences between
groups.
There were no differences between the groups concern-
ing phacoemulsification times and perceptual US powers
(Table 1). As expected, the total surgical time of the combo
surgery was longer than cataract surgery only (group 2B
versus group 1: 𝑡 = 8.2, 𝑝 < 0.001; group 2B versus group
2A: 𝑡 = 8.6, 𝑝 < 0.001).
We observed a significant loss of endothelial cells follow-
ing all procedures (Table 2).
Table 3: Statistical analysis of the differences between pre- and
postoperative data for the three groups (CD: cell density; SD:
standard deviation; CV: coefficient of variation; 6A: hexagonality
coefficient).
Group Parameters CD SD CV 6A
1 versus 2A 𝑡-test 1.306 1.587 0.133 1.846
𝑝 value 0.199 0.12 0.895 0.072
1 versus 2B 𝑡-test 0.792 0.427 0.513 3.661
𝑝 value 0.432 0.671 0.610 0.001
2A versus 2B 𝑡-test 0.743 1.38 0.579 1.557
𝑝 value 0.461 0.175 0.566 0.127
The corneal CD decreased significantly in all groups
after phacoemulsification, with a mean CD reduction of
214.4 cells/mm2 in group 1 (2361.7 ± 477.9 to 2147 ±
455.7 cells/mm2; 𝑝 < 0.01), 362.1 cells/mm2 in group 2A
(2234.5 ± 344.7 to 1872 ± 393.5 cells/mm2; 𝑝 < 0.01), and
290.3 cells/mm2 in group 2B (2476.2 ± 300.6 to 2185.8 ±
393.1 cells/mm2; 𝑝 < 0.01).
The SDandCVdid not differ significantly before and after
surgery in any group.
Finally, the 6A changed significantly after phacoemulsifi-
cation for age-related cataract (group 1: 57.6 ± 10.5 to 51.4 ±
10.1; 𝑝 = 0.015) and phacoemulsification + stent in patients
with POAG (group 2B: 56.3 ± 7.5 to 62.5 ± 10; 𝑝 = 0.016),
though not for POAG treated with phacoemulsification alone
(group 2A: 55.5 ± 13.1 to 55.9 ± 8.9; 𝑝 = 0.865).
In Table 2 the difference between the pre- and postopera-
tive data was reported for the three groups and in Table 3 the
results of the statistical analysis of the same data are shown.
Within the three groups, no significant differences between
pre- and postoperative data were found.
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Table 4: Reported mean endothelial cell loss after cataract surgery
(SICS: small incision cataract surgery; ECD: endothelial cell density)
[20–25].
Author Year Technique Mean ECDloss (%)
Gogate et al. [20] 2010 Phacoemulsification 18.4
SICS 17.7
Reuschel et al. [22] 2010 Phacoemulsification 7.2
Mathew et al. [23] 2011 Phacoemulsification 16.6
Tsuneoka et al. [21] 2002 Phacoemulsification 7.8
Walkow et al. [25] 2000 Phacoemulsification 8.5
Atas¸ et al. [24] 2014 Phacoemulsification 6.41
Present study 2015 Phacoemulsification 12.2
Phacoemulsification + stent 11.71
4. Discussion
The new ab interno glaucoma surgeries through a clear
corneal incision (MIGS) aim at reducing the potential
complications of traditional glaucoma surgery. They present
several other advantages: the sparing of the conjunctiva,
allowing future glaucoma surgery if needed, direct visualiza-
tion of anatomic landmarks, and maintenance of the anterior
chamber with negligible disruption of normal anatomy and
physiology [1].
These new less invasive surgical approaches can easily be
combined with cataract surgery and several studies proved
their efficacy in reducing the IOP [14–17].Nevertheless, all the
new trabecular shunting devices need to be inserted passing
through the anterior chamber and lie in the chamber angle
very close to the corneal endothelium. Although all these
procedures avoid the common complications of trabecular
surgery, they might determine a progressive loss of endothe-
lial cells.
We analyzed the effect of the placement of the Hydrus
stent in patients undergoing combined surgery and we
compared our results with a group of patients with and
without glaucoma after uncomplicated cataract surgery, to
avoid the confounding factor of the damage induced by the
phacoemulsification itself. To our knowledge, there is no
previous report which analyzes corneal endothelial cell loss
after combined surgery with MIGS implant compared to
phacoemulsification alone.
Phacoemulsification determined a loss of endothelial cells
in all groups. Our results are in linewithwhat was reported by
other authors (Table 4). The phacoemulsification parameters
between the three groups were similar as was the degree of
cataract. Although the total surgical time was longer in the
combo group, we did not observe any further damage in this
group of patients. At six months the change in the endothe-
lial parameters after implantation of the Hydrus stent was
comparable to the ones of patients who underwent cataract
surgery. This is extremely important because it is well known
that any device in the anterior chamber can cause some
degree of damage [2, 18–20]. MIGS have been developed to
address patients with mild to moderate glaucoma and any
damage to the corneal endothelium would be considered a
serious adverse event.
Our study presents some limitations: the number of
patients is relatively small (but we must consider that this is
a relatively new procedure), the follow-up is relatively short,
and there is just one postoperative follow-up. Further data
need to be gathered in the future.
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